Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News COMPASS Pathways Plc CMPS

Compass Pathways plc is a United Kingdom-based biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. The Company is engaged in the development of psilocybin treatment, in which its investigational COMP360 psilocybin is administered in conjunction with psychological support, COMP360 psilocybin treatment. COMP360 is its proprietary... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Opinion & Analysis (NDAQ:CMPS)

No current opinion is available.

Bullboard Posts (NDAQ:CMPS)

Compass Pathways Plc (CMPS) Q3 2024 Earnings Call Transcript

Breaking News: $CMPS Compass Pathways Plc (CMPS) Q3 2024 Earnings Call Transcript2024-10-31 21:00:25 ET Image source: The Motley Fool...
whytestocks - October 31, 2024

Trend Tracker for (CMPS)

JUST IN: $CMPS Trend Tracker for (CMPS)2024-10-31 14:30:00 ET Stock Traders Daily has produced this trading report using a proprietary...
whytestocks - October 31, 2024

COMPASS Pathways plc: Advancing Psilocybin Therapy with Prom

http://beyondspx.com/2024/07/31/compass-pathways-plc-advancing-psilocybin-therapy-with-promising-ptsd-data-and-pivotal-trd-trials-on...
MikeTester - August 2, 2024

Should You Buy the Dip on Compass Pathways Stock?

NEWS: $CMPS Should You Buy the Dip on Compass Pathways Stock?2024-06-12 06:25:00 ET If you can do the mental work to separate your...
whytestocks - June 12, 2024

COMPASS Pathways announces publication of positive data from

NEWS: $CMPS COMPASS Pathways announces publication of positive data from treatment-resistant depression phase 2 clinical trial of...
whytestocks - July 17, 2023

Buy for me here, stock seems cheap.

Stage 3 trials
FukDaFed - February 22, 2022